Mary Jo LaDu Selected Research

Neuroinflammatory Diseases

1/2017	EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.
1/2016	Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer's disease in vitro.
5/2015	APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective.
6/2014	Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
11/2010	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
1/2004	ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
1/2004	A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Jo LaDu Research Topics

Disease

40	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 06/2002
8	Inflammation (Inflammations) 02/2021 - 01/2004
7	Neuroinflammatory Diseases 01/2017 - 01/2004
5	Cognitive Dysfunction 01/2020 - 03/2003
3	Dementia (Dementias) 02/2021 - 08/2002
3	Amyloid Plaque 01/2017 - 01/2004
2	Obesity 02/2021 - 10/2019
1	Weight Gain 04/2021
1	Glucose Intolerance 04/2021
1	Type 2 Diabetes Mellitus (MODY) 02/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2021
1	Astrocytoma (Pilocytic Astrocytoma) 02/2021
1	Tauopathies 12/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Hypersensitivity (Allergy) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2010
1	Memory Disorders (Memory Loss) 11/2010
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2010

Drug/Important Bio-Agent (IBA)

20	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2004
18	Apolipoprotein E4IBA 10/2022 - 01/2004
18	Amyloid (Amyloid Fibrils)IBA 01/2018 - 08/2002
15	ApolipoproteinsIBA 02/2021 - 06/2002
8	Apolipoprotein E3IBA 10/2019 - 01/2004
7	Amyloid beta-PeptidesIBA 01/2017 - 08/2002
7	Peptides (Polypeptides)IBA 05/2015 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
4	Apolipoprotein E2IBA 01/2017 - 06/2002
2	Insulin (Novolin)FDA Link 04/2021 - 02/2021
2	Biological ProductsIBA 01/2020 - 03/2003
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2014
2	Bexarotene (LGD1069)FDA Link 01/2017 - 10/2014
2	Amino Acids FDA Link 03/2011 - 01/2011
1	Estrogen Receptor alphaIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Liver X ReceptorsIBA 02/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	LipidsIBA 02/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2021
1	CholesterolIBA 02/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2021
1	Sirtuin 1IBA 12/2018
1	neuronal pentraxinIBA 01/2018
1	Pharmaceutical PreparationsIBA 04/2016
1	PolyphenolsIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2014
1	Lipoproteins (Lipoprotein)IBA 10/2014
1	Protein Isoforms (Isoforms)IBA 01/2011
1	CytokinesIBA 11/2010
1	HDL LipoproteinsIBA 11/2010
1	ChemokinesIBA 11/2010
1	Presenilin-1IBA 11/2010
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2010
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2004

Therapy/Procedure

5	Therapeutics 02/2021 - 11/2010
2	Oral Administration 04/2021 - 02/2021